Old drug, new hope? ivermectin tested for stubborn leishmaniasis rash
NCT ID NCT07286604
First seen Dec 26, 2025 · Last updated May 20, 2026 · Updated 25 times
Summary
This small study tested the safety and effectiveness of the drug ivermectin for people with a skin condition called PKDL, which can appear after recovery from visceral leishmaniasis. Ten otherwise healthy adults with PKDL skin rashes took ivermectin pills for three months. The goal was to see if the drug could clear the skin lesions without causing serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-KALA-AZAR DERMAL LEISHMANIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
Dhaka, 1212, Bangladesh
Conditions
Explore the condition pages connected to this study.